Chemung Financial Corporation operates as a bank holding company for Chemung Canal Trust Company that provides a range of banking, financing, fiduciary, and other financial services. The company provides demand, savings, and time deposits; non-interest and interest-bearing checking accounts; and insured money market deposits. It also offers commercial and agricultural loans comprising loans to small to mid-sized businesses; commercial and residential mortgage loans; and consumer loans, including home equity lines of credit and home equity term loans, as well as automobile loans. In addition, the company provides interest rate swaps, letters of credit, employee benefit plans, insurance products, mutual fund, brokerage, and tax preparation services. Further, it offers guardian, custodian, trustee, investment, pension, estate planning, and employee benefit administrative services, as well as acts as an agent for pension, profit-sharing, and other employee benefit trusts. The company was founded in 1833 and is based in Elmira, New York.…
Chemung Financial Corporation Announces Quarterly Dividend
Chemung Financial (NASDAQ: CHMG) is listed on Nasdaq, where its shares trade in USD. It belongs to the Banks - Regional industry, part of the Financial Services sector, and reports about 348 employees.
The shares were at 79.28 USD on 20 November 2026, up 59.4% over 52 weeks. Its 52-week range is 50.21 USD to 89.34 USD: the price is 11.3% below the high and 57.9% above the low.
At a market capitalisation of 382.35M USD, it trades at 10.1 times trailing earnings and 9.4 times forward earnings. The median trailing P/E of its 20 largest Banks - Regional peers is 10.3, so CHMG is valued in line with them. It pays a dividend yielding 1.76% (it pays out 17% of its earnings), against a median of 4.16% among the dividend payers in that peer group.
Chemung Financial reports return on equity of 5.9%, an operating margin of 41.9% and revenue up 24.8% year over year.
Its debt exceeds its cash by 66.35M USD, a debt-to-equity ratio of 0.55. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 5 analysts cover the stock; their mean price target of 92.35 USD is 16.5% above the current price. The next earnings report is expected on 26 January 2027.